Pazopanib in EWSR1-NFATC2 Translocation-associated Bone Sarcoma
January 12, 2024
PRESS RELEASE: On September 20, 2023, a new case report was published in Oncoscience, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.” continue reading »